These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005. Lietz K, Miller LW. J Am Coll Cardiol; 2007 Sep 25; 50(13):1282-90. PubMed ID: 17888847 [Abstract] [Full Text] [Related]
24. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure]. Matsumura T, Saito T, Miyai I, Nozaki S, Kang J. Rinsho Shinkeigaku; 1999 Jun 25; 39(6):643-8. PubMed ID: 10502990 [Abstract] [Full Text] [Related]
25. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial. Feldman AM, Oren RM, Abraham WT, Boehmer JP, Carson PE, Eichhorn E, Gilbert EM, Kao A, Leier CV, Lowes BD, Mathier MA, McGrew FA, Metra M, Zisman LS, Shakar SF, Krueger SK, Robertson AD, White BG, Gerber MJ, Wold GE, Bristow MR, EMOTE Study Group. Am Heart J; 2007 Nov 25; 154(5):861-9. PubMed ID: 17967591 [Abstract] [Full Text] [Related]
26. The value of intermittent inotropic therapy in unhospitalized patients with refractory heart failure. Moga VD, Luca C, Luca CT, Branea H, Drăgulescu SI. Rom J Intern Med; 1999 Nov 25; 37(1):25-9. PubMed ID: 15523942 [Abstract] [Full Text] [Related]
27. Use of intravenous inotropic therapy in the home. McCloskey WW. Am J Health Syst Pharm; 1998 May 01; 55(9):930-5; quiz 953-4. PubMed ID: 9588252 [Abstract] [Full Text] [Related]
31. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation. Apostolopoulou SC, Vagenakis GA, Tsoutsinos A, Kakava F, Rammos S. Pediatr Cardiol; 2018 Oct 01; 39(7):1315-1322. PubMed ID: 29777282 [Abstract] [Full Text] [Related]
38. Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation. Daneschvar H, Pacher R, Rödler S, Stanek B, Hülsmann M, Grimm M, Laufer G, Wolner E, Bunzel B. Wien Klin Wochenschr; 1996 Feb 01; 108(16):510-4. PubMed ID: 8840497 [Abstract] [Full Text] [Related]
39. Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone? Haglund NA, Cox ZL, Lee JT, Song Y, Keebler ME, DiSalvo TG, Maltais S, Lenihan DJ, Wigger MA. J Card Fail; 2014 Sep 01; 20(9):630-7. PubMed ID: 24954426 [Abstract] [Full Text] [Related]